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Background: Severe aortic stenosis (AS) patients with late gadolinium enhancement (LGE) on cardiovascular
magnetic resonance (CMR) or left ventricular (LV) systolic dysfunction are known to have worse outcome. We
aimed to investigate whether LGE on CMR would be useful in early detection of subclinical LV structural and
functional derangements in AS patients.
Methods: 118 patients with moderate to severe AS were prospectively enrolled. Echocardiography and CMR
images were taken and the patients were divided into groups according to the presence/absence of LGE and of LV
systolic dysfunction (LV ejection fraction (EF) <50%). The stiffness of LV was calculated based on Doppler and CMR
measurements.
Results: Patients were grouped into either group 1, no LGE and normal LVEF, group 2, LGE but normal LVEF and
group 3, LGE with depressed LVEF. There was a significant trend towards increasing LV volumes, worsening of LV
diastolic function (E/e’, diastolic elastance), systolic function (end-systolic elastance) and LV hypertrophy between
the three groups, which coincided with worsening functional capacity (all p-value < 0.001 for trend). Also, significant
differences in the above parameters were noted between group 1 and 2 (E/e’, 14.6 ± 4.3 (mean ± standard
deviation) in group 1 vs. 18.2 ± 9.4 in group 2; end-systolic elastance, 3.24 ± 2.31 in group 1 vs. 2.38 ± 1.16 in group 2,
all p-value < 0.05). The amount of myocardial fibrosis on CMR correlated with parameters of diastolic (diastolic
elastance, Spearman’s ρ = 0.256, p-value = 0.005) and systolic function (end-systolic elastance, Spearman’s ρ = −0.359,
p-value < 0.001).
Conclusions: These findings demonstrate the usefulness of CMR for early detection of subclinical LV structural and
functional deterioration in AS patients.
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Aortic stenosis (AS) is a disease that typically provokes
pressure overload to the left ventricle, which left un-
cured, may lead to left ventricular (LV) hypertrophy,
pump failure and also, to sudden cardiac death [1,2].
Surgery before the development LV dysfunction is of
paramount importance for these patients. Currently,
evaluation of symptomatic status and LV ejection frac-
tion (EF) is recommended for determining surgical tim-
ing [3]. However, sudden cardiac death may occur even
in patients without symptom and LV dysfunction. Fur-
thermore, LV diastolic dysfunction [4] and exercise in-
tolerance [5] often persist even after corrective surgery
suggesting the presence of irreversible myocardial dam-
age before surgery. These disappointing results are partly
due to poor sensitivity of LVEF as a marker of myocar-
dial damage and thus some investigators support early
surgery in asymptomatic patients with normal LVEF [6].
Accordingly, early detection of myocardial damage may
be clinically informative for these patients.
Before the development of overt pump failure, fibrosis
of the LV myocardium ensues [7-9], which leads to dia-
stolic function impairment [10,11] and possibly occult
systolic dysfunction [12-14]. Indeed, patients with severe
stenosis of the valve show significant deterioration of the
diastolic properties that improves after correction of this
stenosis [10,15]. More importantly, the aggravation of
diastolic dysfunction is closely related to clinical out-
come [16].
Late gadolinium enhancement (LGE) cardiovascular
magnetic resonance (CMR) is the most accurate way to
visualize the smallest focal fibrosis/scar in the myocar-
dium [14,17]. Patients with severe AS who had LGE on
CMR were more likely to experience worse outcome
than those who did not [5,18-20]. Also, the degree of
LGE has also been shown to correlate well with the
degree of histological fibrosis in these patients [5]. In
this report, we investigated whether CMR can be used
to detect subclinical deterioration of the ventricular
function. Especially, we focused on whether LGE-CMR
would discriminate the subtle difference of cardiac func-
tion in patients with normal LVEF.
Methods
Patient population
A total of 118 patients with moderate to severe AS, i.e.
maximal transaortic velocity >3 m/sec or mean
transaortic pressure gradient >30 mmHg and aortic
valve area ≤1.5cm2were enrolled to this prospective
study from September 2009 to September 2012 at both
Seoul National University Hospital and Samsung Med-
ical Center, which was composed of a series of echocar-
diography and CMR. Patients were consecutively
enrolled at the time of echocardiographic examination.Patients with significant concomitant valvular disease of
more than mild degree, i.e. moderate aortic regurgitation
or moderate mitral valve disease or a previous history of
cardiac surgery or myocardial infarction were excluded.
All except 9 patients underwent conventional coronary
angiography or computed tomography coronary angiog-
raphy for determination of significant concomitant cor-
onary artery disease. All patients gave informed consent
to the study, the protocol of which was approved by the
Institutional Review Board of both institutions. Baseline
laboratory tests, anthropometric measures and medical
history were taken at the time of echocardiography.
Body surface area was calculated with the Mosteller
formula.
Echocardiography
All patients underwent a comprehensive echocardiog-
raphy with a commercial equipment (Vivid 7, GE Medical
System, Horten, Norway) according to the current recom-
mendations [21].
In brief, LV dimensions both at end-diastole and
systole were measured at the standard parasternal short-
axis view of papillary muscle level or parasternal long-
axis view. The dimensions of the aortic root, i.e. aortic
annulus, sinotubular junction and ascending thoracic
aorta diameter were measured at the standard paraster-
nal long-axis view.
Peak early and late diastolic velocity at the mitral valve
tip level (E, A velocity, respectively) and mitral annular
velocity (e’, a’ velocity, respectively) at the septal annulus
were measured at the standard apical four-chamber
view. Transaortic mean pressure gradient and maximal
velocity was measured at all views possible, i.e. apical 5 or
3 chamber, subcostal, right parasternal and suprasternal
notch view. Aortic valve area (AVA) was calculated using
the continuity equation after acquiring time-velocity in-
tegral at the aortic valve level and also, left ventricular
outflow tract level. All echocardiography measurements
were averaged for three beats for patients in sinus
rhythm and five beats in atrial fibrillation with baseline
heart rate of <100BPM.
Calculation of LV load and stiffness parameters
The diastolic properties of the LV were estimated using
the following parameters. LV filling pressure was
assessed by using a well-known surrogate parameter E/e’
[22] and to estimate the diastolic elastance of the LV
(Ed), E/e’ was again divided by the stroke volume mea-
sured by CMR [23].
To estimate the systolic stiffness of LV, single beat-
derived LV end-systolic elastance (Ees) was calculated as
end-systolic pressure/end-systolic volume (measured by
CMR) [24], where end-systolic pressure was calculated
as 0.9 × (systolic blood pressure).
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Cardiac magnetic resonance imaging was performed
using a 3.0-T scanner with phased-array receiver coils
(Sonata Magnetom, Siemens, Erlangen, Germany) under
the standard protocols. In brief, steady-state free preces-
sion cine images under an adequate breath-hold were
performed to visualize the LV wall motion and also, to
quantify the LV function and mass. The entire LV short-
axis images were acquired at a 6 mm interval from the
base to apex to include the whole LV volume. The LGE
images were acquired 10 minutes after intravenous
gadolinium injection (0.1 mmol/kg Magnevist; Schering,
Berlin, Germany). The protocol for the LGE images were
as follows; slice thickness 8 mm, interslice gap 2 mm,
TR 9.1 msec, TE 42 msec, flip angle 13 degrees, in-plane
resolution 1.4 × 1.9 mm. Inversion delay time varied
from 280 ~ 360 msec according to the time to null the
normal myocardium.
LGE-CMR images were analyzed by an experienced
radiologist blinded to the patients’ information. In
addition, the region of myocardial fibrosis was defined
as the sum of pixels with signal intensity above 5SD of
the normal remote myocardium at each short-axis slice
[18], using an appropriate post-processing program
(CMR42, Circle Cardiovascular Imaging Inc., Calgary,
Canada). Summation of the measured areas of LGE and
the whole myocardium in all short-axis slices yielded the
total volume of LGE and the total volume of LV. The
percentage of myocardial fibrosis per total myocardium
(%LGE-positive myocardium) was analyzed as the total
pixels of fibrosis per total pixels of myocardium.
In addition, the pattern of LGE was classified according
to the following classification. The subendocardial LGE
pattern was designated if the LGE was located at the
subendocardium. All other forms of LGE were located
along the midwall except for one patient with linear en-
hancement at the epicardium. If the LGE spanned at least
half of a single myocardial segment, it was defined as a lin-
ear pattern LGE or otherwise it was defined as a spot pat-
tern LGE. The LGE pattern showing a diffuse fuzzy
pattern of enhancement was defined as a patchy pattern
LGE. Patients with a mixed pattern of LGE categorized
above was classified according to the predominant pattern
of LGE.
Statistical analysis
Continuous variables are presented as mean (SD). The
difference between two groups was compared using Stu-
dent’s t-test. The difference between three groups was
calculated using analysis of variance (ANOVA). Bivariate
correlation analysis between the parameters of myocar-
dial function, i.e. diastolic and end-systolic elastance,
and the percentage of myocardial fibrosis per total myo-
cardium was drawn. The results of the strength ofcorrelation were presented as Spearman’s rho correlation
coefficients because of the non-normal distribution of
the percentage of myocardial fibrosis per total myocar-
dium. Dichotomous variables are presented as number
(percentage) and compared using χ2-test. All analysis
was done with SPSS version 16.0 (SPSS Inc., Chicago,
IL) and two-tailed p-value of <0.05 was considered sta-
tistically significant.Results
A total of 118 moderate to severe AS patients were pro-
spectively enrolled for the current study (Table 1). Ap-
proximately half of these patients showed LGE on CMR
and 15% of the patients had LV systolic dysfunction de-
fined as LVEF < 50% on CMR. However, there was no
patient with LV systolic dysfunction but without LGE.
Therefore, the patients were grouped into three as the
following; group 1, no LGE on CMR and normal LV sys-
tolic function, group 2, LGE on CMR but normal LV sys-
tolic function, and group 3, LGE on CMR and also
depressed LV systolic function (Figure 1).
Baseline clinical characteristics are summarized in
Table 1. In brief, there were no significant differences in
basic anthropometric measures except for the smoking
status. All except 5 patients in group 1 and 4 patients in
group 2 underwent evaluation for the presence of signifi-
cant concomitant coronary artery disease but there was
no difference.
The baseline echocardiography parameters are sum-
marized in Table 2. Compared with group 1 and 2, the
patients in group 3 had significantly larger LV dimen-
sions, shorter deceleration time and smaller mitral septal
annular velocity. Also as a consequence of LV systolic
dysfunction in group 3, the peak transaortic velocity was
smaller on Doppler echocardiography. There was a ten-
dency towards thicker interventricular septum and pos-
terior wall thickness in group 2 compared with group 1.
On CMR, there were significant differences in all param-
eters, including LV volumes, LV systolic function, cardiac
index and also, LV mass (Table 3) between group 1, 2
and 3.
Although there was no significant difference in the
AVA between the three groups (Figure 2A), stepwise dif-
ferences were noted between the three groups in both
end-diastolic and end-systolic volumes resulting in a sig-
nificant trend towards larger LV in group 3 (Figure 2B).
There was also significant difference in the degree of
hypertrophy between the three groups (Figure 2C).
Interestingly, although there was no significant differ-
ence in the EF between group 1 and 2 (Table 3), the vol-
umes and mass in group 1 and 2 were notably different,
suggesting subclinical adverse LV remodeling in group 2
(Figure 2B and 2C).
Table 1 Baseline clinical characteristics of the study participants
Total (n = 118) Group 1 (n = 54) Group 2 (n = 45) Group 3 (n = 19) p-value
Age (years) 68 (10) 68 (10) 68 (10) 69 (11) 0.929
Male, n (%) 34 (50.0) 23 (56.1) 11 (40.7) 11 (40.7) 0.215
Systolic blood pressure (mmHg) 125 (18) 128 (18) 125 (16) 118 (20) 0.108
Diastolic blood pressure (mmHg) 69 (11) 70 (12) 69 (12) 66 (9) 0.349
Body surface area (m2) 1.65 (0.17) 1.65 (0.16) 1.67 (0.18) 1.63 (0.17) 0.681
Baseline creatinine (mg/dL) 0.93 (0.23) 0.92 (0.25) 0.92 (0.20) 0.95 (0.22) 0.877
Hypertension, n (%) 68 (57.6) 33 (61.1) 25 (55.6) 10 (52.6) 0.763
Diabetes mellitus, n (%) 29 (24.6) 10 (18.5) 13 (28.9) 6 (31.6) 0.364
Hyperlipidemia, n (%) 25 (21.2) 17 (31.5) 6 (13.3) 2 (10.5) 0.410
Current smoker, n (%) 22 (18.6) 6 (11.1) 8 (17.8) 8 (42.1) 0.011
Atrial fibrillation, n (%) 10 (8.5) 5 (9.3) 2 (4.4) 3 (15.8) 0.317
Coronary artery disease, n (%)§ 16 (14.7) 8 (16.3) 5 (12.2) 3 (15.8) 0.849
All patients were grouped according to the presence/absence of late gadolinium enhancement (LGE) and left ventricular (LV) systolic dysfunction, defined as LV
ejection fraction (EF) < 50%. Group 1 was defined as normal LVEF and no LGE on CMR, group 2 as normal LVEF with LGE on CMR, group 3 as depressed LVEF with
LGE on CMR. The difference of baseline clinical characteristics between the three groups was calculated using analysis of variance (ANOVA) and the results
presented as p-value. NYHA, New York Heart Association. The data are presented as mean (SD) or number (percentage). §The evaluation of the presence/absence
of coronary artery disease was evaluated in 109 patients.
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cation and the span width of the LGE (Figure 3). Al-
though the proportion of patients with subendocardial
LGE pattern (Figure 3A) was similar in group 2 and 3
(14/45 (31.1%) in group 2 vs. 6/19 (31.6%) in group 3),
the proportion of patients with spot pattern (Figure 3B)Figure 1 Grouping of the study population and representative LGE-C
to the presence/absence of late gadolinium enhancement (LGE) and left vent
Group 1 was defined as normal LVEF and no LGE on CMR (left upper qua
quadrant), group 3 as depressed LVEF with LGE on CMR (right lower quadran
(C) Representative cine and LGE-CMR images of a patient in group 2. (D) Repwas lower in group 3 than group 2 (21/45 (46.7%) in
group 2 vs. 4/19 (21.1%) in group 3). On the contrary,
the linear LGE pattern (Figure 3C) was more frequent in
group 3 (4/45 (8.9%) in group 2 vs. 7/19 (36.8%) in
group 3). The proportion of patients with patchy pattern
(Figure 3D) were similar between the two groups (6/45MR images of the patients. (A) All patients were grouped according
ricular (LV) systolic dysfunction, defined as LV ejection fraction (EF) < 50%.
drant), group 2 as normal LVEF with LGE on CMR (right upper
t). (B) Representative cine and LGE-CMR images of a patient in group 1.
resentative cine and LGE-CMR images of a patient in group 3.
Table 2 Echocardiographic parameters of the study participants
Total (n = 118) Group 1 (n = 54) Group 2 (n = 45) Group 3 (n = 19) p-value
LVEDD (mm) 51 (5) 49 (5) 50 (5) 59 (7)‡ <0.001
LVESD (mm) 33 (8) 30 (4) 31 (4) 46 (9)‡ <0.001
IVST (mm) 12 (5) 11 (2) 13 (6)* 13 (6) 0.080
PWT (mm) 11 (2) 10 (2) 11 (2)* 11 (2) 0.036
Aortic annulus diameter (mm) 21 (2) 21 (2) 21 (3) 22 (3) 0.902
E (m/sec) 0.77 (0.28) 0.73 (0.23) 0.79 (0.28) 0.83 (0.40) 0.386
DT (m/sec) 252 (78) 246 (71) 270 (81) 226 (85)† 0.088
e’ (cm/sec) 4.8 (1.6) 5.3 (1.7) 4.7 (1.3) 3.9 (1.6)† 0.005
Vmax (m/sec) 4.7 (0.8) 4.6 (0.8) 4.9 (0.8)* 4.3 (0.7)‡ 0.015
AVA (cm2) 0.76 (0.21) 0.79 (0.20) 0.75 (0.21) 0.70 (0.25) 0.291
AVA index (cm2/m2) 0.46 (0.13) 0.48 (0.13) 0.45 (0.12) 0.43 (0.14) 0.234
Transaortic mean PG (mmHg) 54 (22) 52 (21) 59 (19) 50 (28) 0.152
The data are presented as mean (SD). The difference of each parameters between the three groups was calculated using analysis of variance (ANOVA) and
between the two groups with Student’s t-test and the results presented as p-value. LV, left ventricle; EDD/ESD, end-diastolic/systolic diameter; IVST, interventricular
septal thickness; PWT, posterior wall thickness; E, early diastolic velocity at mitral valve tip; DT, deceleration time; e’, early mitral annular velocity at the septal
annulus; Vmax, maximal transaortic velocity; AVA, aortic valve area; PG, pressure gradient.*p < 0.01 versus group 1, †p < 0.01 versus group 2,‡p < 0.05 versus
group 2.
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Altogether, the pattern of LGE was slightly different
between the two groups (p-value = 0.038).
Next, we analyzed whether there was any difference
between the three groups in the functional remodeling
parameters of the LV, i.e. diastolic and systolic function,
which is summarized in Table 4. Left ventricular filling
pressure, as estimated by E/e’ and diastolic elastance, Ed
were compared. There was a significant trend towards
worse diastolic function as shown by the gradual in-
crease of E/e’ and Ed by the groups (Figure 4A and 4B).
In terms of end-systolic elastance (Ees), there was also
a significant trend towards decreasing end-systolic
elastance and also, significant difference in the end-
systolic elastance between the 3 groups (Figure 4C). It
was also notable that the stiffness parameters, Ed and
Ees, in group 1 and 2 were different, which suggested ad-
vanced LV functional impairment in group 2 (Figure 4B
and 4C). Altogether, there was a significant trend towards
worse functional capacity (Figure 4D).Table 3 CMR parameters of the study participants
Total (n = 118) Group
LV end-diastolic volume index (mL/m2) 98.9 (33.5) 84
LV end-systolic volume index (mL/m2) 41.0 (30.1) 28
LV ejection fraction (%) 61.4 (15.1) 67
LV cardiac index (L/min/m2) 3.94 (1.07) 3.7
LV mass index (g/m2) 100.8 (37.4) 86
LGE(+) myocardium/total myocardium (%) 4.18 (5.75)
The data are presented as mean (SD). The difference of each parameters between t
between the two groups with Student’s t-test and the results presented as p-value.
**p < 0.05 versus group 1,‡p < 0.05 versus group 2.To dissect the association of the degree of myocardial
fibrosis with LV functional remodeling, correlation
between the % fibrosis and diastolic stiffness parameter,
Ed or systolic stiffness parameter, Ees was drawn. There
was a positive correlation between Ed and % LGE-
positive myocardium (Figure 5A, Spearman’s ρ = 0.256,
p = 0.005), in contrast to negative correlation between
Ees and % LGE-positive myocardium (Figure 5B,
Spearman’s ρ = −0.359, p < 0.001). In addition, there
was a positive correlation between E/e’ and % LGE-
positive myocardium (Spearman’s ρ = 0.233, p = 0.012)
and between e’ and % LGE-positive myocardium
(Spearman’s ρ = −0.248, p = 0.007). Also, there was a
positive correlation between LV mass index by CMR
and % LGE-positive myocardium (Figure 5C, Spearman’s
ρ = 0.319, p < 0.001). However, all of the correlation
degrees were weak. The correlation between % LGE-
positive myocardium and the AS severity was non-
significant (Spearman’s ρ = −0.139, p = 0.134 for indexed
AVA; Spearman’s ρ = −0.042, p = 0.650 for transaortic mean1 (n = 54) Group 2 (n = 45) Group 3 (n = 19) p-value
.7 (22.9) 97.3 (25.1)** 143.4 (38.9)‡ <0.001
.5 (13.2) 35.1 (16.5)* 90.6 (39.3)‡ <0.001
.3 (9.8) 65.3 (9.7) 35.2 (10.6)‡ <0.001
2 (1.03) 4.35 (1.05)** 3.50 (0.88)‡ 0.002
.0 (29.6) 108.0 (40.9)** 125.5 (31.2) <0.001
0 6.91 (5.03) 9.60 (7.16) <0.001
he three groups was calculated using analysis of variance (ANOVA) and





























































































Figure 2 Structural LV remodeling assessed with CMR according to the group. (A) No significant trend in AVA (solid line) nor indexed AVA
(dotted line) according to the group of patients. (B) Significant trend in both indexed LV end-diastolic volume (solid line) and indexed LV end-
systolic volume (dotted line) according to the group of patients. P-value for trend <0.001 in both parameters. (C) Significant trend in indexed LV
mass according to the group of patients. *p < 0.01 versus group 1, **p < 0.05 versus group 1, ‡p < 0.05 versus group 2.
Subendocardial Spot Linear Patchy p-value
Group 2 
(n=45)
14 (31.1) 21 (46.7) 4 (8.9) 6 (13.3) 0.038
Group 3 
(n=19)
6 (31.6) 4 (21.1) 7 (36.8) 2 (10.5)
A B C D
Figure 3 Diverse pattern of LGE in the cohort. (A) A subendocardial pattern of LGE. (B) A spot pattern LGE with single fibrosis region or multiple
fibrosis areas. (C) A linear pattern LGE, spanning at least half of a myocardial segment. (D) A patchy pattern LGE. p-value = 0.038 for χ2-test.
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Table 4 Left ventricular (LV) chamber stiffness parameters of the study participants
Total (n = 118) Group 1 (n = 54) Group 2 (n = 45) Group 3 (n = 19) p-value
E/e’ 17.3 (8.3) 14.6 (4.3) 18.2 (9.4)* 22.9 (10.8) <0.001
Ed (mL-1) 0.20 (0.12) 0.17 (0.06) 0.20 (0.12) 0.31 (0.16)‡ <0.001
Ees (mmHg/mL) 2.54 (1.91) 3.24 (2.31) 2.38 (1.16)* 0.93 (0.56)‡ <0.001
The data are presented as mean (SD). The difference of each parameters between the three groups was calculated using analysis of variance (ANOVA) and
between the two groups with Student’s t-test and the results presented as p-value. Ed, diastolic elastance; Ees, end-systolic elastance.*p < 0.01 versus group 1,
‡p < 0.05 versus group 2.
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transaortic velocity).Discussion
By dividing the study population into 3 groups according
to the presence/absence of LGE and LV systolic dysfunc-
tion on CMR, parameters predictive of outcome in se-
vere AS patients [5,18-20,25], we could show that there
is a trend towards adverse structural and functional re-
modeling in severe AS patients if there is LGE and LV
systolic dysfunction on CMR. More importantly, even if
the LVEF was normal, those with LGE on CMR had sig-
nificantly stiffer LV compared with those without, which
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Figure 4 Functional LV remodeling assessed with CMR according to t
pressure, according to the group of patients. (B) Significant trend in diasto
according to the group of patients. (C) Significant trend in end-systolic ela
group of patients. P-value for trend <0.001 for all parameters.*p < 0.01 versu
patient was graded according to the New York Heart Association (NYHA) c
according to the group of patients. See Figures 1 and 2 for other symbolsdetection of subclinical LV structural and functional de-
terioration in severe AS patients with normal LVEF.
Basic pathophysiologic mechanism underlying the LV
response to AS
The LV loaded with chronic pressure undergoes hyper-
trophy according to the Laplace’s law, which is also ac-
companied by elevation of end-diastolic pressure [26].
Following this, the myocardial perfusion pressure falls
[27] and subsequently, myocardial ischemia ensues. The
eventual endpoint of this cascade is cardiomyocyte
apoptosis, myocardial fibrosis replacing the apoptotic
myocytes [7] and subsequently, gradual deterioration of
the LV systolic function. In our cohort of patients, none




























he group. (A) Significant trend in E/e’, a parameter of LV filling
lic elastance (Ed), a parameter of diastolic LV chamber stiffness,
stance, a parameter of systolic LV chamber stiffness, according to the
s group 1, ‡p < 0.05 versus group 2. (D) The functional status of each
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Figure 5 Correlation of LV functional parameters and LV mass with the degree of myocardial fibrosis. LGE was considered present when
the signal intensity of the index myocardial segment was greater than 5SD of the remote normal myocardial signal. (A) Positive correlation
between the degree of LGE and diastolic LV chamber stiffness (diastolic elastance, Ed), (B) negative correlation between the degree of LGE and
systolic LV chamber stiffness (end-systolic elastance, Ees) and (C) positive correlation between the degree of LGE and indexed LV mass.
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had some degree of LGE in the myocardium. These
findings support a general cascade of ‘Aortic valve
stenosis→ LV hypertrophy→Myocardial fibrosis→
Ventricular stiffness’.
Previous studies in AS patients have demonstrated that
the degree of myocyte apoptosis and myocardial fibrosis
correlates well with the degree of LV systolic function de-
terioration [7]. Also, the degree of myocardial fibrosis
detected by endomyocardial biopsy tended to show a sig-
nificant trend to myocyte hypertrophy and LV dilatation
[5]. These findings verify that the above concepts are in-
deed the situation that occurs in the setting of AS.
Analysis of our cohort demonstrated a significant
trend towards increase of LV volume, mass and LV sys-
tolic/diastolic stiffness according to the presence of LGE
and LVEF depression, which is in line with the above
concepts and findings. This trend in our paper provides
a proof-of-concept about the structural pathophysiologic
response in AS and how myocardial fibrosis is related to
the LV remodeling process.
Myocardial function in severe AS and its relationship with
LGE
Several previous papers have demonstrated that LVEF
may not be an optimal parameter for reflecting the truemyocardial function in severe AS [28,29]. More specific-
ally, there are a substantial proportion of patients with
normal EF that display significant depression of myocar-
dial contractility [12-14] and subsequently a worse prog-
nosis [28,30]. In this aspect, our paper provides direct
evidence that even focal myocardial scar demonstrated
on CMR may be related to ventricular stiffness in both
diastolic and systolic phase, which is line with a previous
paper demonstrating a similar finding [5]. As discussed
above, the demonstration of focal scar may be a marker
of the degree of cardiomyocyte apoptosis, which in turn
may turn out to be deterioration of the systolic and dia-
stolic ventricular function.
It has been suggested that the midwall mechanics of
LV may be the determinant of myocardial contractility
in AS [31]. Although the patterns of LGE are diverse in
patients with AS, it was interesting to see a significant
proportion of patients with midwall fibrosis [20] in our
cohort. Moreover, patients with overt LV systolic dys-
function (LVEF < 50%) were more likely to demonstrate
a linear pattern of LGE in the midwall, suggesting an im-
portant role of midwall contractility. Importantly, a re-
cent paper has nicely shown that the midwall LGE
carries a similar risk of mortality as the infarct pattern
LGE [20], which could be explained by the depression of
the myocardial contractility.
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Although the general concept of ‘Aortic valve stenosis→
LV hypertrophy→Myocardial fibrosis→Ventricular
stiffness’ has been previously reviewed in previous pa-
pers [26] and our analysis as well, the results of our
paper also demonstrated that the correlation between
each step may not be robust. For example, there was no
significant correlation between the degree of aortic valve
area and myocardial fibrosis, which suggest that aortic
stenosis per se may be only one of the contributing fac-
tors accelerating myocardial fibrosis.
Although only a few papers have addressed this ques-
tion directly, factors such as age [5], diabetes [11] and
genetic polymorphism [32] have all been suggested as
‘contributors’ of myocardial fibrosis. The pace of AVA
change may also affect the degree of LVH. Furthermore,
previous study has also demonstrated that the correlation
between AVA and the degree of LVH may be poor [33].
These suggest that the process directing ‘Aortic valve sten-
osis→Myocardial fibrosis’ is a multifactorial process in-
volving various factors in between and that the severity of
AS should also take into account the ventricular response
to pressure overload rather than the numerics associated
with the valve itself [34]. Also, in this context, parameters
directly assessing diffuse myocardial fibrosis such as
postcontrast T1 values [35] or T1 mapping with various
CMR sequences [36] and its correlation with ventricular
function are awaited in the future.
Utility of CMR in detection of subclinical myocardial
dysfunction
One of the most interesting and novel finding in this
paper is that even in patients with normal systolic func-
tion, patients with LGE tend to have stiffer LV chamber,
elevated E/e’ and Ed and lower Ees. These findings tell
us that even in patients with normal EF, a process of
subclinical LV dysfunction ensues in patients with LGE
on CMR. Although there have been reports demonstrat-
ing the prognostic value of LGE on CMR in patients
with AS [5,18,20], the guidelines dealing with the timing
of intervention uses only LVEF as the criteria for sur-
gery. As suggested in a recent review of adjunct criteria
for assessment of AS [29], our data suggests that the re-
sult of LGE-CMR may be integrated as an adjunct cri-
teria for surgical intervention in these group of patients.
Limitations of the study
Our paper is not without limitations. First, the size of the
population was not large. However, the accurate assess-
ment of LV volume, function and mass by CMR demon-
strated that, in spite of the small sample size, there was a
significant difference in these parameters between patients
with versus without LGE. Moreover, our cohort is one of
the largest reports so far in terms of AS assessed withCMR. Furthermore, out cohort is the largest one to com-
bine two imaging modalities simultaneously for assessing
the remodeling of LV in AS patients. Second, we cannot
provide a definite clinical implication as to whether the
stiffness parameters are predictors of outcome in these pa-
tients. However, there was a significant trend toward
worse functional capacity in patients with LGE and LV
systolic dysfunction, which suggests that patients with
LGE may do worse than those without as in previous pa-
pers [5,19,20]. We do think that more data is desperately
needed on the functional outcome in the future. Third,
the degree of LGE was not matched with the histological
findings. However, it has been persistently shown by previ-
ous papers that the degree of LGE shows robust correl-
ation with the degree of histological fibrosis [5,18].
Conclusion
In conclusion, our analysis results demonstrate that with
the use of CMR, it may be possible to detect subclinical
LV structural and functional deterioration in moderate
to severe AS patients. The efficacy of studying LV re-
modeling comprehensively in predicting the ventricular
structural and functional remodeling in these patients
warrants further in-depth investigation.
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